KORU Medical Systems, Inc. reported strong third-quarter 2024 financial results and raised its full-year 2024 guidance for revenue, gross...

Quince Therapeutics, a late-stage biotechnology company focused on treating rare diseases, provided a pipeline update and financial results for...

Omeros Corporation recently announced its third-quarter 2024 financial results and provided updates on its clinical development programs. The company...

TAE Life Sciences (TLS), a prominent developer of boron neutron capture therapy (BNCT) technology and related boron target drugs,...

DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, has initiated its Phase 2 investigator-sponsored trial for DM199, a potential preeclampsia...

In this interview, we speak with Jeff Bennett, CEO of Morari Medical, about the challenges and strategies in developing...

In this interview, we speak with Davidi Vortman, CEO of UltraSight, about their innovative AI-driven ultrasound technology and how...

The design of a study’s protocol is pivotal to its success in clinical trials, and engaging study sites early...

GenSight Biologics has submitted an updated regulatory file for its LUMEVOQ® gene therapy to the French medicines safety agency...

CARMAT’s Aeson® artificial heart has seen increased adoption as a European bridge-to-transplant solution. By the end of October 2024,...